The authors reported that 200–500 EpCAMhigh/CD44+ cells promoted tumorigenesis in non-obsese diabetic/severe combined immunodeficient mice, while no tumor was produced by injection of 104 EpCAMlow/CD44− cells. Here, CD44 is linked to neoplasm.